MRD Monitoring in Acute Lymphoblastic Leukemia
0 Vues
• 06/15/23
0
0
Intégrer
administrator
Les abonnés
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Montre plus
Commentaires de Facebook
SORT BY-
Meilleures Commentaires
-
Derniers Commentaires